These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

422 related items for PubMed ID: 16451297

  • 1. Ivabradine -- the first selective sinus node I(f) channel inhibitor in the treatment of stable angina.
    Sulfi S, Timmis AD.
    Int J Clin Pract; 2006 Feb; 60(2):222-8. PubMed ID: 16451297
    [Abstract] [Full Text] [Related]

  • 2. Heart rate lowering by specific and selective I(f) current inhibition with ivabradine: a new therapeutic perspective in cardiovascular disease.
    DiFrancesco D, Camm JA.
    Drugs; 2004 Feb; 64(16):1757-65. PubMed ID: 15301560
    [Abstract] [Full Text] [Related]

  • 3. Review of the If selective channel inhibitor ivabradine in the treatment of chronic stable angina.
    Prasad UK, Gray D, Purcell H.
    Adv Ther; 2009 Feb; 26(2):127-37. PubMed ID: 19259630
    [Abstract] [Full Text] [Related]

  • 4. Ivabradine: beyond heart rate control.
    Riccioni G, Vitulano N, D'Orazio N.
    Adv Ther; 2009 Jan; 26(1):12-24. PubMed ID: 19165437
    [Abstract] [Full Text] [Related]

  • 5. Ivabradine: new drug. Best avoided in stable angina.
    Prescrire Int; 2007 Apr; 16(88):53-6. PubMed ID: 17458043
    [Abstract] [Full Text] [Related]

  • 6. Heart rate slowing versus other pharmacological antianginal strategies.
    Diaz A, Tardif JC.
    Adv Cardiol; 2006 Apr; 43():65-78. PubMed ID: 16936473
    [Abstract] [Full Text] [Related]

  • 7. Characterization of the heart rate-lowering action of ivabradine, a selective I(f) current inhibitor.
    Borer JS, Le Heuzey JY.
    Am J Ther; 2008 Apr; 15(5):461-73. PubMed ID: 18806523
    [Abstract] [Full Text] [Related]

  • 8. Ivabradine: pharmacodynamic aspects of its clinical use.
    Stieber J.
    Methods Find Exp Clin Pharmacol; 2008 Oct; 30(8):633-41. PubMed ID: 19088948
    [Abstract] [Full Text] [Related]

  • 9. Selective and specific I(f) inhibition: new perspectives for the treatment of stable angina.
    Fox K.
    Expert Opin Pharmacother; 2006 Jun; 7(9):1211-20. PubMed ID: 16732707
    [Abstract] [Full Text] [Related]

  • 10. Antianginal efficacy and safety of ivabradine compared with amlodipine in patients with stable effort angina pectoris: a 3-month randomised, double-blind, multicentre, noninferiority trial.
    Ruzyllo W, Tendera M, Ford I, Fox KM.
    Drugs; 2007 Jun; 67(3):393-405. PubMed ID: 17335297
    [Abstract] [Full Text] [Related]

  • 11. Ivabradine in chronic stable angina: Effects by and beyond heart rate reduction.
    Camici PG, Gloekler S, Levy BI, Skalidis E, Tagliamonte E, Vardas P, Heusch G.
    Int J Cardiol; 2016 Jul 15; 215():1-6. PubMed ID: 27104917
    [Abstract] [Full Text] [Related]

  • 12. Focus on ivabradine: a new heart rate-controlling drug.
    Riccioni G.
    Expert Rev Cardiovasc Ther; 2009 Feb 15; 7(2):107-13. PubMed ID: 19210206
    [Abstract] [Full Text] [Related]

  • 13. Efficacy of the I(f) current inhibitor ivabradine in patients with chronic stable angina receiving beta-blocker therapy: a 4-month, randomized, placebo-controlled trial.
    Tardif JC, Ponikowski P, Kahan T, ASSOCIATE Study Investigators.
    Eur Heart J; 2009 Mar 15; 30(5):540-8. PubMed ID: 19136486
    [Abstract] [Full Text] [Related]

  • 14. Ivabradine: a selective If current inhibitor in the treatment of stable angina.
    Andrikopoulos G, Dasopoulou C, Sakellariou D, Tzeis S, Koulouris S, Kranidis A, Kappos K, Manolis AS.
    Recent Pat Cardiovasc Drug Discov; 2006 Nov 15; 1(3):277-82. PubMed ID: 18221092
    [Abstract] [Full Text] [Related]

  • 15. Efficacy of ivabradine, a selective I(f) inhibitor, in patients with chronic stable angina pectoris and diabetes mellitus.
    Borer JS, Tardif JC.
    Am J Cardiol; 2010 Jan 01; 105(1):29-35. PubMed ID: 20102886
    [Abstract] [Full Text] [Related]

  • 16. [Ivabradine--the first selective and specific I(f) inhibitor, novel preparation for treatment of stable angina].
    Belousov IuB, Erofeeva SB, Maneshina OA.
    Kardiologiia; 2006 Jan 01; 46(8):36-48. PubMed ID: 17047598
    [Abstract] [Full Text] [Related]

  • 17. [Ivabradine -- a novel approach for heart rate lowering].
    Er F, Hoppe UC.
    Dtsch Med Wochenschr; 2005 Jun 17; 130(24):1501-2. PubMed ID: 15942839
    [No Abstract] [Full Text] [Related]

  • 18. Relationship between ivabradine treatment and cardiovascular outcomes in patients with stable coronary artery disease and left ventricular systolic dysfunction with limiting angina: a subgroup analysis of the randomized, controlled BEAUTIFUL trial.
    Fox K, Ford I, Steg PG, Tendera M, Robertson M, Ferrari R, BEAUTIFUL Investigators.
    Eur Heart J; 2009 Oct 17; 30(19):2337-45. PubMed ID: 19720635
    [Abstract] [Full Text] [Related]

  • 19. I(f) inhibition in cardiovascular diseases.
    Thollon C, Vilaine JP.
    Adv Pharmacol; 2010 Oct 17; 59():53-92. PubMed ID: 20933199
    [Abstract] [Full Text] [Related]

  • 20. Angina: Ivabradine for treatment of stable angina pectoris.
    de Silva R, Fox KM.
    Nat Rev Cardiol; 2009 May 17; 6(5):329-30. PubMed ID: 19377492
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.